InMode (INMD) FCF Payout Ratio Growth (3y) (2021 - 2026)
InMode (INMD) FCF Payout Ratio Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | -24.36% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | -15.73% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 0.06% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 47.27% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | -478.95% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 0.49% |
| 10 | InMode | 913.43 Mn | 498.26 Mn | 71.52 Mn | 83.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.17% |
| Sep 30, 2025 | 82.95% |
| Jun 30, 2025 | 68.54% |
| Mar 31, 2025 | 95.18% |
| Sep 30, 2024 | 52.62% |
| Jun 30, 2024 | 18.35% |
| Mar 31, 2024 | 24.24% |
| Dec 31, 2023 | 12.53% |
| Sep 30, 2023 | 12.27% |
| Jun 30, 2023 | -58.41% |
| Mar 31, 2023 | -15.80% |
| Dec 31, 2022 | 1.54% |
| Sep 30, 2022 | -22.42% |
| Jun 30, 2022 | 6.17% |
| Mar 31, 2022 | -38.65% |
| Dec 31, 2021 | -20.85% |
| Sep 30, 2021 | -21.62% |
| Jun 30, 2021 | -19.82% |